Hennessy Advisors Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.13M Buy
296,113
+63,013
+27% +$1.65M 0.23% 126
2026
Q1
$6.55M Buy
233,100
+39,000
+20% +$1.04M 0.24% 131
2025
Q4
$4.83M Sell
194,100
-10,800
-5% -$272K 0.17% 153
2025
Q3
$5.22M Sell
204,900
-3,200
-2% -$79K 0.18% 150
2025
Q2
$5.04M Hold
208,100
0.17% 155
2025
Q1
$5.27M Buy
208,100
+34,300
+20% +$898K 0.18% 151
2024
Q4
$4.61M Sell
173,800
-6,300
-3% -$171K 0.14% 151
2024
Q3
$5.21M Hold
180,100
0.17% 149
2024
Q2
$5.04M Sell
180,100
-3,700
-2% -$102K 0.19% 145
2024
Q1
$5.1M Buy
183,800
+5,200
+3% +$144K 0.21% 126
2023
Q4
$5.14M Sell
178,600
-6,800
-4% -$206K 0.26% 105
2023
Q3
$6.15M Sell
185,400
-4,200
-2% -$149K 0.43% 61
2023
Q2
$6.95M Sell
189,600
-8,900
-4% -$346K 0.5% 57
2023
Q1
$8.1M Buy
198,500
+89,700
+82% +$3.87M 0.6% 51
2022
Q4
$5.58M Sell
108,800
-2,000
-2% -$95.9K 0.37% 87
2022
Q3
$4.85M Buy
110,800
+1,200
+1% +$58.3K 0.34% 100
2022
Q2
$5.75M Hold
109,600
0.34% 93
2022
Q1
$5.67M Sell
109,600
-23,300
-18% -$1.21M 0.3% 123
2021
Q4
$7.85M Sell
132,900
-3,100
-2% -$154K 0.45% 71
2021
Q3
$5.85M Sell
136,000
-2,100
-2% -$93K 0.35% 92
2021
Q2
$5.41M Sell
138,100
-4,850
-3% -$189K 0.3% 107
2021
Q1
$5.18M Sell
142,950
-35,950
-20% -$1.28M 0.3% 97
2020
Q4
$6.58M Sell
178,900
-77,433
-30% -$2.84M 0.42% 74
2020
Q3
$8.93M Sell
256,333
-30,408
-11% -$1.07M 0.62% 51
2020
Q2
$8.9M Sell
286,741
-9,222
-3% -$313K 0.62% 43
2020
Q1
$9.16M Buy
295,963
+29,828
+11% +$1.02M 0.69% 30
2019
Q4
$9.89M Buy
266,135
+1,265
+0.5% +$45.1K 0.5% 65
2019
Q3
$9.03M Sell
264,870
-1,107
-0.4% -$40.3K 0.45% 63
2019
Q2
$10.9M Sell
265,977
-12,701
-5% -$504K 0.52% 56
2019
Q1
$11.2M Sell
278,678
-27,669
-9% -$1.11M 0.52% 60
2018
Q4
$12.7M Sell
306,347
-11,173
-4% -$464K 0.62% 54
2018
Q3
$13.3M Sell
317,520
-14,598
-4% -$562K 0.49% 59
2018
Q2
$11.4M Sell
332,118
-5,955
-2% -$204K 0.39% 68
2018
Q1
$11.4M Buy
338,073
+3,639
+1% +$125K 0.38% 69
2017
Q4
$11.5M Sell
334,434
-5,218
-2% -$178K 0.35% 72
2017
Q3
$11.5M Sell
339,652
-7,483
-2% -$241K 0.36% 67
2017
Q2
$11.1M Sell
347,135
-13,280
-4% -$419K 0.34% 68
2017
Q1
$11.7M Buy
360,415
+57,495
+19% +$1.81M 0.34% 70
2016
Q4
$9.34M Buy
302,920
+17,549
+6% +$536K 0.28% 78
2016
Q3
$9.17M Buy
285,371
+24,664
+9% +$825K 0.26% 92
2016
Q2
$8.71M Buy
260,707
+6,008
+2% +$192K 0.26% 83
2016
Q1
$7.16M Buy
254,699
+2,635
+1% +$75.3K 0.22% 96
2015
Q4
$7.72M Sell
252,064
-20,659
-8% -$650K 0.24% 96
2015
Q3
$8.13M Sell
272,723
-36,784
-12% -$1.18M 0.24% 93
2015
Q2
$9.85M Sell
309,507
-5,481
-2% -$179K 0.29% 75
2015
Q1
$10.4M Sell
314,988
-6,956
-2% -$221K 0.3% 74
2014
Q4
$9.52M Buy
321,944
+6,798
+2% +$195K 0.27% 87
2014
Q3
$8.84M Sell
315,146
-1,318
-0.4% -$37K 0.26% 87
2014
Q2
$8.91M Sell
316,464
-316
-0.1% -$9.01K 0.28% 82
2014
Q1
$9.65M Sell
316,780
-12,121
-4% -$361K 0.36% 65
2013
Q4
$9.56M Buy
328,901
+6,324
+2% +$184K 0.39% 54
2013
Q3
$8.79M Sell
322,577
-14,018
-4% -$381K 0.4% 48
2013
Q2
$8.95M Buy
+336,595
New +$9.3M 0.45% 45

Other funds holding PFE

Hennessy Advisors Inc's PFE Position: Q2 2026 in Review

Hennessy Advisors Inc increased its Pfizer (PFE) stake by 27% in Q2 2026, buying an estimated $1.65M and bringing the position to 296,113 shares worth $7.13M. The position accounts for 0.23% of the portfolio, ranked #126.

Hennessy Advisors Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q3 2018. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hennessy Advisors Inc held 296,113 shares of Pfizer worth $7.13M as of Q2 2026.
  • Hennessy Advisors Inc bought 63,013 Pfizer shares in Q2 2026, an estimated $1.65M.
  • Pfizer made up 0.23% of Hennessy Advisors Inc's portfolio in Q2 2026, its #126 holding.
  • Hennessy Advisors Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Hennessy Advisors Inc's Pfizer position peaked at $13.3M in Q3 2018.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.